Skip to Content
Still using that old version of Internet Explorer? This site will work much better in a newer version of IE or Firefox.
Download Internet Explorer 8 or Firefox 3 now!

antigens

Francis Ndungu

francis-ndungu.jpg
Email: 
fndunguatkilifi [dot] kemri-wellcome [dot] org
Group: 
Molecular Parasitology and Immunology

Immunity to malaria is slow to develop, is non-sterilising and wanes rapidly when immune adults migrate to non-endemic regions, suggesting that specific problems exist in the establishment and main

Quality (avidity) of the antibody response to specific malaria antigens

Full Title: 
Is the quality (avidity) of the antibody response to specific malaria antigens associated with clinical protection?

No description available.

T cell responses to PfEMP1

Principal Investigator(s): 
Britta C Urban

This research team investigates whether the phenotypic and antigenic properties of variant antigens expressed on the red cell surface of Plasmodium faciparum isolates determine cellular and humoral immune responses to that isolate.

Identifying the merozoite targets of naturally acquired immunity to malaria

Principal Investigator(s): 
Faith Osier

We are currently studying antibody responses to a panel of merozoite antigens that are leading candidates for malaria blood stage vaccines including Merozoite surface proteins (MSP) -1, -2 and -3, Apical membrane antigen 1 (AMA-1), Erythrocyte binding antigen 175 (EBA-175) and Glutamate rich protein (GLURP).

Impact of natural immunity on expression of Plasmodium falciparum variant surface antigens

Full Title: 
Measuring the impact of naturally acquired immunity on the expression of Plasmodium falciparum variant surface antigens
Principal Investigator(s): 
Pete Bull

Plasmodium falciparum infected erythrocytes express on their surface, members of a diverse family of parasite molecules called PfEMP1 that are encoded by a family of 60 var genes in every parasite genome. These molecules interact with the surface of host cells and mediate parasite sequestration in tissues including the brain, an important step in the pathogenesis of cerebral malaria. Although naturally acquired antibodies to PfEMP1 provide specific protection against the molecular variants that they recognise, PfEMP1 are often considered too diverse to be vaccine candidates.

Pete Bull

peter-bull-photo-thumb.jpg
Email: 
pbullatkilifi [dot] kemri-wellcome [dot] org
Group: 
Molecular Parasitology and Immunology

My group aims to identify new targets of malaria intervention by identifying and characterizing subsets of PfEMP1 that are associated with infections of children with low natural immunity at differ

Vandana Thathy

vandana-thathy.jpg
Email: 
vthathyatkilifi [dot] kemri-wellcome [dot] org
Group: 
Molecular Parasitology and Immunology

The deadliest human malaria parasite, Plasmodium falciparum, infects red blood cells during part of its lifecycle, producing the symptoms of malaria.